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Objectives. This study describes the technique, clinical eharar- 
t&tics and rertdts of the tint 50 patients undergoing pereuiane. 
ous hallova perirardiotcmy aspart OE a multicenter registry. 
Background. Percutaneous balloon pericsrdio,om~ InvoIves 
the use cd a percutancms balhwn dilating csthefer to create a 
nansurgtcnt prtcardiat window. 
Metfmds. Patiinta eligible for prcutaneous batlwn pericar- 
dintamy had either cardiac tampon& (II = 36) ur a moderate to 
large perlcardlal effaslon (tt = 14). In addition to clinical follow- 
UD, wrial ethocardiims end ckesl X-w films were obtained. 
Results. The p&ha was cmtsidered &cessful in 46 patients 
after P mean lolls-up pert& oP3.6 + 3.3 months. Two pattents 
required an early opwatton, one for bleeding fmm a pertemdiat 
vmel and cm for per&tent perirardial catheter drainage. Two 
patients required a late operation for 
?vlinor complications of Iiw procedure inc 
first 37 patients (studied ixfm the pphylactk me of a&di~ 
agenti). thoracentesb or chest h& placement io 8 and P smalt 
spontaneously resolving pmumotkwax in 2. Despite fke s&t- 
term sum of this procedure, the taas_tem prqmis c.f tk 441 
patients with malignant pricardial dkve w&red poor (man 
survival time 3.3 f 3.1 months). 
Conclusions. percutaaeats ballwa pricardiotomy is stem 
Cal in helping to manage !xge pericvdial etTi&ns, @i&arly in 
patients itb a mnligoant modition. It may Lwcome the preFerred 
treafment t0 avoid P nmre invasive prardvre for ptieotr with 
pericwiiil et&s&m and P ttmttfd tife exp+ctawy. 
N Am coil Cu&/ 1993;21:1-5) 
Patients with pericardial tampon& due to a malignant 
condition arc poor candidates for surgical therapy. Their life 
expectancy may be so limited that the longer hospital stay 
assac;dted with a surgical procedure may comprise a major 
portion of their remaining life span. Additionally, the mal- 
nubition and chemotherapy associated with advanced ma- 
lignancy increase the risks of infection and other periopera- 
tive complications. 
Recommended therapy for recurrent malignant wicar- 
dial disease has been either pericardiocentcsis accompanied 
by insfiliaoon of sclerosing (I) or chemotherapeutic agents 
o; subxiphoid surgical per&dial windowing iZ-6). R&r- 
rcnce ram arc 13% to 50% after oericardioeemesis (7-9) and 
4.9% after subaiphoid surgical &dowing. Because sobxi- 
pboid surgical windowing does not appear to improve SW- 
vwal and IS associated wilh a modest periopcrative risk (IO). 
the technique of percutaneous balloon pericardiotomy was 
proposed by Palacios et al. (I I) as a less invasive alternative 
iha; also &oids the small but cumulative risks of repeared 
peiicardiocentesis. 
In rhis study we describe the first SO patients undergoing 
percutaneous balloon pericardiotomy as part of a muiti- 
center tcgistry. 
Methods 
Study patients. Fifty patients studied undewent pcrcuta- 
ncous balloon pericardiotomy between My 2. 1987 and 
February 4. 1992 in eight centers. This won includes 
follow-up on the previously reported eight patients studied 
between July 2. 1987 and September 17, 1990 (II). The 
clinical characteristics of these 50 patients are shown in 
Table I. Per&dial tamponade was present in 36 patients 
(72%), I4 (28%) had large effusions and were believed to be 
at risk for tamponadr 2nd tite vast majority (88%) had a 
history of malignancy. 
Percutaneous balloon pericardiotomy was performed ei- 
ther as primary therapy at the time of initial pericardiocen- 
tesis was deferred therapy after pericardiocentesis. Patients 
were eligible for the procedure as primary therapy if they 
had clinical or echocardiographic evidence of pericardial 
tampanade or a moderete to large effusion. Patients who 
underwent percutaneous balloon pericardiotamy as deferred 
therapy after pericardiocentesis had persistent drainage 
(>I00 ml/day for 3 days) from the pericardial catheter or 
recurrent effusion after catheter removal. No patient had 
undergone prior pericardial instillation of sclerosing agents. 
Twelve patients had had prior mediastinal irradiation. All 
patients gave informed consent in accordance with Institu- 
tional Review Board and Radiation Safety Committee guide- 
lines. Patients with refractory coagulopathy were excluded. 
After a patient eligible for percutaneous balloon pericar- 
diutomy was identified, an echocardiogram and chw X-ray 
film were obtained before the procedure was performed. 
Description of percutaneous ballarm pericardiotomy tech- 
nique. After administration of local anesthesia to the skin 
and deeper tissues with B 22.gauge spinal needle. the wri- 
cardium was entered with an 18.g&e per&dial needle 
with use of a standard subxiphoid approach. A 0.035.in. 
(0.089 cm1 x 80.cm J tip guide wire was advanced into the 
Figure 1. Drawing illustrating the percutaneous ballwn pericardiot- 
omy technique. The dilating balloon is advanced overa guide wire to 
straddle the pericsrdisl margin: it is then manually inflated to create 
the pericardial window. 
pericardial space and the needle removed. The tract of the 
needle was dilated with an 8F dilator. and an 8F oeticardial 
catheter (either pigtail or straight with sideholes) was ad- 
vanced into the per&dial space. 
After wricardial r~rcssure was measured. oericardial fluid 
was withbrawn for laboratory studies. App&imatel y IO0 to 
200 ml of fluid was left within the twicardium to omvide a 
measure of safety if catheter displacement o&red and 
repeat needle entry was necessary. 
Twenty milliliters of dilute (50%) radiographic contrast 
medium was injected into the per&dial space to aid visu- 
alization. A 0.038.in. (0.097 cm) extra stiff I tip guide wire 
was then advanced into the pericardial space. so that it 
looped within the pericardial space. The pet&dial catheter 
was removed and the tract dilated with a IOF dilator. A 
ing 30% radiographic contrast medium was advanced over 
the guide wire to straddle the pericardial border. Gentle 
inflation of the balloon was used to locate the per&dial 
margin (Fig. IL If the pericardium was aomxed to the chest 
wall. as indicated by failure of the prox&d pation of the 
balloon to expand, the catheter was gently advanced while 
the skin was pulled in the opposite direction to isolate the 
pericardium for dilation The balloon was manually inflated 
to create the window. 
After dilation. the balloon was removed and the pericar- 
dial catheter replaced over the wire. The wire was removed 
and contrast medium was manually injected through the 
catheter as it was slowly withdrawn until the side holes were 
just within the pericardial space. T!.:- IO to IS ml ofcontrast 
medium was mpldly injected to determine the presence of 
free fluid exit. 
If free passage of contract medium from the pcncs;dial 
space WE not seen. at rhe operaror’s discretion a second 
window was performed by entering the pencardium more 
laterally with respect to the imt~al site. Before the second 
pericardial site WBF entered. the 0.038.in. wide wire was left 
in place to protect access until the wxndLite of pericardial 
entry was confirmed. The pencard~al catheter was iben 
advanced well into the pericardial space. All remaining 
pericardial fluid was drained and the volume rccordcd 
The final pericardial pressure was recorded and right heart 
hemodynamics was reasaesred. 
A combination of benzodlazepme and morphine was 
administered intravenously for sedation and pain control. All 
patients were continuously monitored by digital pulse orim- 
etry. RI@ heart catheterization wth dctcrmination of car- 
diac output by thermodilution was performed before and 
after balloon pericardiotomy. 
Posiproeedure management and follow-up. After the pro- 
cedure, the pericardial catheter war aspirated every 6 hand 
Rushed with heparin (5 ml, iW U/ml). Pericardial drainage 
volumes were recorded and the catheter was removed when 
drainage was <1OOmllday. Postprocedure echocardiography 
and chest radiography were performed to monitor. re~pcc- 
tively. possible reaccumulation of pericardtal fluid or devel- 
opment of a left pleural effusion caused by drainage of the 
pericardial fluid. These studies were obtained 24 h after 
catheter removal and at I, 2.3.6 and I2 months of follow-up. 
DeRnltions and statistical methods. The procedure was 
considered successful if echocardiograms obtained during 
the follow-up period revealed minimal or no pericardial fluid. 
The procedure was considered to have failed in any patient 
who required surgery to treat a complication. A requirement 
for thoracentesis or chest tube placement within 30 days of 
percutaneous bailoon pericardioromy was considered a re- 
sult of per&dial drainage into the pleural space. Results are 
presented as mean values * SD for continuous variables. 
Proadural &dings. Percutaneous belloon pericardiot- 
omy was performed a$ primary therapy at the time of initial 
pericardiocentesis in 25 of the 50 patients and as deferred 
therapy after failed pericardiocentesis with indwelling cath- 
eter drainage in the other 25. Factors related to the cathe- 
terization laboratory technique are l&ted in Table 2. The 
mean volume of pericardial~fluid removed at the time cf 
percutaneous balloon pericardiotomy was 617 2 410 ml 
(range 0 to 2,WO). Dilating balloon size ranged from IS to 
25 mm; a 20.mm balloon was used in 45 patients. In two 
patients whose oericardium was resistant to dilation with a 
&le ballwn. two 20.mm balloons were simultaneously 
inflated. Iniection of radioeraohic contrast medium throueh 
the catheter was performedin’ patients: free Row from tie 
pericardium was seen in 27. In an attempt to achieve free 
ex.n oi comra~i medium from the pericardium, a second 
pericardial site wac dilated in 22 patients. Results ofcytology 
were positive in 23 of 39 patients with a history of malig- 
nancy in wham pericxdial fluid was rvailable for analysis. 
Follow.up findings (Table 3). Percutaneoun balloon peri- 
cardiotomy was successful in 46 patients (92%). The pres- 
ence or absence of free exit of contrast from :he pericardium 
did not correlate wilh procedural success. There were no 
wnificanl diRrences in outcome between procedures per- 
fomxd as primary or deferred treatment. In four patients the 
procedure ‘war considered to have failed because of the 
recurrence of pcricardiai effusion or the need for surgery to 
treat complications of percutaneous balloon paicardiotomy. 
The two patients with recurrent pericardial e&ions had 
malignancy: one had adenocarcinoma of unknown primary 
site. the other bad leukemia 2nd was found to have pericar- 
dial involvement by asper&illus. Both underwent surgical 
pericardial windowing. One had a right ventricular tear at the 
time of operation. Postoperatively both patients developed 
moderate recurrent pericardial effusionr without tamponade. 
Both died of their malignant condition. 
Of the two patients who required surgery for complica- study of tetracycline instillation. technical failure or rerw- 
lions, one withwemic pericardi& had bleeding from ~SIEIII rence of per&dial effusion occurred in 17% of 58 patients 
wicardial vessel that required surgery to achieve hemosta- (16). The use of subxiphoid pericardial windowing has beca 
sir. The other had a history of & cancer. mediastinal advocated as primary therapy for malignant ~ericardial 
irradiation and coronary artery bypass grafting. After pax- tamponade because of its high rate of mitial success in 
taneous oalloon pericardiotomy, he had persistent drainage relieving tamponade (Z-6) and the low recurrence rate (17). 
from the per&dial catheter and was referred for surgical 
windowing by means of median stemotomy. At the time of 
exploration, a 2.cm pericar&i window was found to com- 
municate freely with the left pleural space. This window was 
enlarged further surgically; however; paicardial fluid again 
recurred during the follow-up period. 
The mean duration of follow-up was 3.6 + 3.3 months 
(range 0.1 to 12.2). Thirty of the 50 patients died. All those 
who died had a prior history of malignancy. Of those who 
died, the mean survival time was 3.3 c3.1 months (range 0.1 
to 10.9). One patient was lost to follow-w. 
Complicatibns included fever, which o&red in 6 of the 
first 37 patients, none with documented bacteremia or posi- 
tive pericardial drainage cultures. After the protocol was 
modified to include routine administration of prophylactic 
antibiotic drugs, no febrile episodes were seen in the subse- 
quent 13 patients. After percutaneous balloon pericardiot- 
omy, a left pleural effusion developed or was seen in most 
patients, presumably indicating passage of paicardial fluid 
into the pleural space. Thoracentesis or chest tube place- 
ment was performed within 30 days of percutaneous balloon 
pericardiotomy in eight patients (six of whom had preexist- 
ing pleural effusions). In two patients a small left apical 
pneumothorax was seen that resolved spontaneously within 
24 h and was assumed to be caused by entrance of extrinsic 
air through the pericardial catheter with free passage of air 
from the pericardial into the pleural space. 
More extensive pericardial resection is usually reserved for 
those patients anticipated to have longer survival. Transtho- 
racic windowing offers none of the advantages of subxiphoid 
windowing and is associated with a higher reoperation rate 
(20.8%), which may be due to early obstruction by adherent 
lung. Compared with total pericardiectomy or per&dial 
window by anterior thoracotomy. subxiphoid windowing has 
lower postoperative morbidity (10% vs. 67%) (18). 
Thus, recommended therapy for recurrent malignant peri- 
cardial disease has been either pericardiocentesis accompa- 
nied by instillation of sclerosing or chemotherapeutic agents 
(1.16,19) or suhxiphoid surgical windowing. Percutaneous 
balloon pericardiolomy may provide a less invasive altema- 
tive to subxiphoid surgical windowing while avoiding the 
risk of recutrent pericardial et&ion after pericardiocentesis 
with sclerotberapy. Although the high success rates for 
percutaneous balloon pericardiotomy described here may in 
part reflect the 25 patients who underwent balloon pericar- 
diotomy as primary therapy, there was no ditTerence in 
~ecumnce rates when those patients were compared with 
the 25 who underwent percutaneous balloon paicardiotomy 
after prior unsuccessful pericardiocentesis. 
Procedural eonsideratkms. The risks of percutaneous bal- 
loon paicardiotomy include all those associated with peri- 
cardiccentesis. To avoid right ventricular laceration or COT. 
onary injury, the needle should be advanced under 
electrocardiographic or Ruoroscopic guidance. In addition, 
the wire should be seen iluoroscopically to be looping within 
the oericardium rather than beinn entraooed within the 
I . . 
pericardiotomy registry is the first to describe the use of this 
technique in a large group of patients. Pericardial disease 
Discussion 
remains an important clinical problem in tht management of 
advanced malicnant conditions. Postmortem studies of oa- 
tients with m&nancy reveal an incidence of cqdiac or 
This report from the multicenter percutirneous balloon 
pericardial metaetases to be 2% to 21% (12-14). Conversely, 
among patients seen initially with pericardial tamponade. a 
malignant condition is found to be the etiologic factor in 
39%. Short-term survival in pericardial tamponade is prima- 
rily dependent on early diagnosis and relief of tamponade. 
quences. percutaneous balloon pericordiotom; should be 
attempted only by physicians who have extensive experi- 
myocardium or passing to the pulmonary artery. Because 
ence with pericardiocentesis. In the emergency setting. it 
inadvertent introduction of the wire (and later the balloon) 
may be prudent to stabilize the patient with pericardiocen- 
tesis and leave a catheter in place for elective percutaneous 
into the right ventricle would have catastrophic conse- 
balloon pericardiotomy under more controlled conditions. 
Percutaneous balloon pericardiotomy permits pericardial 
fluid to pass into the left pleural or peritoneal spaces where 
resorptive capacity is greater. In some patients the increased 
Row of pericardial fluid into the pleural space may necessi. 
Long-term survival depends on the prognosis of the primary 
illness irrespective of the intervention performed (10,IS). 
tate tho&entesis or chest tube &cement. Be&e pleural 
effusions freauentlv accomoanv oericardial disease. it is 
Comparison with other forms of trebtment of pwicardial difficult to d&r&e how iani bf our study patients re- 
effwion and tampmade. The mnnagegement of pericardial quired pleural interventions solely as a result of percutane- 
tamponade and pericardial et&Sian remains controversial. It 
is well accepted that pericardiocentesis can provide imme- 
ous balloon pericardiotomy. Six of the eight patients who 
underwent pleural drainage wilhin 30 days of percutaneous 
diate hemodynamic mprovement. But recurrence rates after 
pericardiocentesis range from 13% to 50% (1.7-9). In one 
balloon pericardiotomy had preexisting effusions evident on 
chest X-ray film. 
Reported experience with subxiphoid pericardiai win- 
dows (29; suggests :Sat the percutaneous balloon window is 
unlikely to remain open indefinitely. However. the balloon 
procedure may permit effective pelicardial decompression to 
take place, thereby maintaining a fluid-free pericardial space 
for a prolonged period during which autosclerosis can occur. 
This possibility may explain why percutaneous balloon 
pericardiotomy is successful in many patients who have 
been unsuccessfully treated with simple pericardiocentesis 
;vith indwelling catheter drainage. 
A pericardial catheter was left in place after percutaneous 
balloon pericardio,omy to monitor drainage in all 50 pa- 
tients. However, it may he possible to perform the proce- 
dure without leaving a pericardial catheter in place. permit- 
ting an even shorter hospital stay and further decreasing the 
risks of infection. 
One advantage of surgical pericardial windowing is that 
tissue can be obtained for histopathologic analysis. With ,he 
adjunctive use of percutaneous per&dial bioptome. tissue 
sampling can be performed simultaneously with percutane- 
ous balloon pericardiotomy (21). 
Complications and limitations. After febrile episodes 
were seen in 6 of the first 37 patients (none with documented 
bacteremia or positive pericardial drainage cultures). the 
routine use of prophylactic antibiotic drugs was begun. No 
febrile episodes were seen in the subsequent I3 patients. It is 
unclear whether this difference represents efticacy of pro- 
phylactic antiboiotic drugs in the prevention of low grade 
infection, a random effec, or greater operator experience 
with a concomitant decrease in procedural time and catheter 
manipulation. 
The limited lie expectancy of patients with advanced 
malignant disease favors a less invasive procedure such as 
percutaneous balloon pericardiotomy. Experience with non- 
malignant pricardial disease remains limited. The one pa- 
tie,,, who required rurgery for pericardial bleeding had 
uremic platelet dysfunction. thus raising concern about the 
safety of percutaneous balloon pericardiotomy in patients 
with platelet dysfunction or other coagulopathies. 
Conclusions. Our exnxience with the first 50 oatiettts in 
the registry indicates that percutaaneous balloon pericardiot- 
omy appears to provide successful palliation of malignant 
pericardial disease in most patients for the duration of their 
survival. This “less invasive” procedure may become the 
preferred primary treatment for malignant pericardial tam- 
ponade. Long-term follow-up study is needed on larger 
numbers of patients to clarify the mle of percutaneous 
balloon pericardiotomy in the management of nonmalignant 
pericardial disease. 
